1. Rare Disease Day

    Posted on February 29, 201611:27 pm

      Today, the last day in February, is Rare Disease Day when the world pauses for a moment to focus on often overlooked diseases that affect relatively few people but in such a devastating way. Among rare diseases Duchenne muscular dystrophy is actually quite rare because it affects less than 20,000 boys in the U.S. Read more »

  2. Capricor Therapeutics Announces First Patient Treated In HOPE-Duchenne Clinical Trial

    Posted on February 22, 20161:19 pm

      CureDuchenne is pleased to see our biotech partner Capricor Therapeutics progress with their HOPE-Duchenne clinical trial. Capricor announced today the treatment of the first patient with Duchenne muscular dystrophy-related cardiomyopathy with CAP-1002 in the HOPE-Duchenne Phase I/II clinical trial. The patient was treated at the Cincinnati Children’s Hospital Medical Center under the direction of Read more »

  3. Update on Phase 3 Tadalafil Trial

    Posted on February 3, 20167:08 pm

    We are sharing the following information from Lilly on their Phase 3 Tadalafil Trial   We are writing to share disappointing news about our Phase 3 study of tadalafil in approximately 330 patients with Duchenne muscular dystrophy (DMD). We recently completed analysis of the initial data from the placebo controlled, double-blind period of the trial, Read more »